Ronald Muhlenkamp's Firm Buys 3 Stocks in 4th Quarter

Guru’s firm also gains a position in Bristol-Myers Squibb following its acquisition of Celgene Continue reading… …read more

Source:: Yahoo Finance

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.